Merck
CN
  • Development of a novel genetically modified bioluminescent-bacteria-based assay for detection of fluoroquinolones in animal-derived foods.

Development of a novel genetically modified bioluminescent-bacteria-based assay for detection of fluoroquinolones in animal-derived foods.

Analytical and bioanalytical chemistry (2014-10-31)
Guyue Cheng, Xiaobing Dong, Yulian Wang, Dapeng Peng, Xu Wang, Haihong Hao, Shuyu Xie, Wei Qu, Zhenli Liu, Zonghui Yuan
摘要

Fluoroquinolones (FQNs) are broad-spectrum antibacterial agents widely used in animal husbandry and aquaculture. The residues and antimicrobial resistance of such antibiotics are a major public health concern. To realize multianalyte detection of FQN residues, a genetically modified bacterium, Escherichia coli pK12 harboring plasmid pRecAlux3, was constructed in this study to develop a bioluminescent-bacteria-based assay for the detection of FQNs in animal-derived foods. This assay was based on the principle of induction of an SOS response by FQNs via inducing the recA-promoter-fused luciferase reporter gene existing on the plasmid pRecAlux3. E. coli pK12 was able to recognize 11 FQNs: difloxacin, enrofloxacin, ciprofloxacin, sarafloxacin, norfloxacin, danofloxacin, ofloxacin, pefloxacin, lomefloxacin, marbofloxacin, and orbifloxacin. This method could be applied to 11 edible tissues, including milk, fish muscle, and the muscles, livers, and kidneys of cattle, chickens, and pigs, with a very simple and rapid sample extraction procedure using only phosphate-buffered saline. The limits of detection of the FQNs were between 12.5 and 100 μg kg(-1), all of which were lower than the maximum residue limits. Most of the recoveries of the FQNs were in the range from 60 to 120 %, and the interassay coefficients of variation were less than 30 %. This method, confirmed by high-performance liquid chromatography, is reliable and can be used as both a screening test and a semiquantitative assay, when the identity of a single type of FQN is known.

材料
货号
品牌
产品描述

Sigma-Aldrich
环丙沙星, ≥98% (HPLC)
Sigma-Aldrich
红霉素, BioReagent, suitable for cell culture
Sigma-Aldrich
萘啶酸, ≥98%
Supelco
环丙沙星, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
恩诺沙星, ≥99.0%
Supelco
恩诺沙星, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
红霉素, potency: ≥850 μg per mg
Sigma-Aldrich
红霉素, meets USP testing specifications
Supelco
诺氟沙星, analytical standard, ≥98% (TLC)
Supelco
环丙沙星, VETRANAL®, analytical standard
Sigma-Aldrich
氧氟沙星, fluoroquinolone antibiotic
Supelco
恩诺沙星, VETRANAL®, analytical standard
Supelco
氧氟沙星, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
恶喹酸, quinolone antibiotic
Sigma-Aldrich
磺胺二甲基嘧啶, 99.0-101.0% (on dried basis)
Supelco
磺胺二甲基嘧啶, VETRANAL®, analytical standard
Supelco
麻保沙星, VETRANAL®, analytical standard
Supelco
恶喹酸, analytical standard
Supelco
萘啶酸, analytical standard
Supelco
磺胺喹噁啉, PESTANAL®, analytical standard
Supelco
达氟沙星, VETRANAL®, analytical standard
Supelco
氧氟沙星, VETRANAL®, analytical standard
Supelco
奥比沙星, VETRANAL®, analytical standard
Supelco
诺氟沙星, VETRANAL®, analytical standard
USP
氧氟沙星, United States Pharmacopeia (USP) Reference Standard
环丙沙星, European Pharmacopoeia (EP) Reference Standard
USP
恩诺沙星, United States Pharmacopeia (USP) Reference Standard
磺胺二甲嘧啶, European Pharmacopoeia (EP) Reference Standard
恩诺沙星, European Pharmacopoeia (EP) Reference Standard
麻保沙星, European Pharmacopoeia (EP) Reference Standard